Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

6.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.5K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

1.7K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to recombinant human granulocyte colony-stimulating factor in reticular dysgenesis.

Journal of human immunity·2026
Same author

Viral Membrane-Targeting Amphipathic Helical Peptide Ligands for Colorimetric Sandwich Assays of Influenza A Virus Particles.

ACS sensors·2026
Same author

Dissecting Epstein-Barr Virus Dependence Across Diverse Infected Cell Models.

bioRxiv : the preprint server for biology·2025
Same author

Longitudinal antibody titers measured after COVID-19 mRNA vaccination can identify individuals at risk for subsequent infection.

Science translational medicine·2025
Same author

Association of Epstein-Barr virus genomic alterations with human pathologies.

Blood·2025
Same author

Cullin-5 deficiency promotes chimeric antigen receptor T cell effector functions potentially via the modulation of JAK/STAT signaling pathway.

Nature communications·2024

Related Experiment Video

Updated: Jan 13, 2026

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
09:43

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

Published on: March 30, 2018

9.6K

Epstein-Barr Virus-Associated T/NK-Cell Neoplasms.

Yoshitaka Sato1, Yusuke Okuno2, Takayuki Murata3

  • 1Department of Virology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Journal of Medical Virology
|January 9, 2026
PubMed
Summary
This summary is machine-generated.

Epstein-Barr virus (EBV)-associated T/NK-cell neoplasms share genetic alterations, but effective treatments are limited. Further research into molecular subtypes and large cohorts is crucial for developing precision therapies.

Keywords:
ANKLCAEBVEBVENKTLHV‐LPDT/NK neoplasms

More Related Videos

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines
06:38

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines

Published on: November 8, 2011

41.2K
Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
08:44

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Published on: September 7, 2022

2.8K

Related Experiment Videos

Last Updated: Jan 13, 2026

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
09:43

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

Published on: March 30, 2018

9.6K
Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines
06:38

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines

Published on: November 8, 2011

41.2K
Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
08:44

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Published on: September 7, 2022

2.8K

Area of Science:

  • Hematology
  • Oncology
  • Virology

Background:

  • Epstein-Barr virus (EBV) drives a range of T- and natural killer (NK)-cell neoplasms, from chronic disorders to aggressive lymphomas.
  • These neoplasms exhibit a spectrum of clinical presentations and include extranodal NK/T-cell lymphoma (ENKTL) and aggressive NK-cell leukemia.

Purpose of the Study:

  • To explore the continuum of EBV-associated T/NK-cell neoplasms.
  • To identify shared host genetic alterations and understand EBV's role in oncogenesis.
  • To highlight the need for improved therapeutic strategies.

Main Methods:

  • Genomic and epigenetic analyses of EBV-associated neoplasms.
  • Review of existing literature on disease spectrum and genetic alterations.
  • Analysis of viral gene expression in oncogenesis.

Main Results:

  • Shared host genetic alterations in JAK-STAT signaling, epigenetic regulators, TP53, and DDX3X are identified across EBV-associated T/NK-cell neoplasms.
  • Defective EBV influences viral gene expression, contributing to cancer development.
  • Current treatments like l-asparaginase-based chemoradiotherapy show promise for early-stage ENKTL but are insufficient for advanced disease.

Conclusions:

  • EBV-associated T/NK-cell neoplasms represent a continuum driven by host genetic alterations and viral factors.
  • Effective treatments for advanced-stage disease and other EBV-driven neoplasms are urgently needed.
  • Molecular subclassifications and prospective studies are essential for advancing precision therapeutic strategies.